Emergent BioSolutions (EBS) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.01 +2.04%
EPS Growth %: -31.3%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -31.3%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $2.19, $0.07 better than the analyst estimate of $2.12. Revenue for the quarter came in at $385.2 million versus the consensus estimate of $437.93 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- CVG to join Russell 2000 and Russell 3000 indexes June 26
- Qualcomm investor day to detail data center plans Wednesday
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
